Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Uncategorized

Opinion: BIO CEO Jim Greenwood on ‘New Ways to Increase Patient Access to Needed Medications’

Jim Greenwood

Jim Greenwood

Washington, DC, January 10, 2017Biotechnology Innovation Organization (BIO) President and Chief Executive Officer James C. Greenwood writes in The Hill:

With a new year comes a new administration and a new Congress and a new opportunity to educate and inform stakeholders on the value of biopharmaceuticals and the biopharmaceutical industry.

It’s often forgotten that our uniquely American industry provides not only treatments and cures to sick patients, but also millions of good-paying jobs to Americans in practically every state. Continue reading

HHS Awards $ 19.8 Million to Takeda to Accelerate Development of a Zika Vaccine

Zika 3Washington, DC, September 4, 2016 — The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will provide an initial $19.8 million over the next 18 months to Takeda Vaccines, Inc. of Deerfield, Illinois, a subsidiary of the Takeda Group headquartered in Japan, to develop a Zika vaccine for use in the United States.

Under the contract, ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will provide funding to complete studies that should enable the company to file an Investigational New Drug application with the U.S. Food and Drug Administration.

If the application is approved, the first clinical (human) trials of the vaccine could begin next year. Continue reading

CDC Study Sheds Light on How Some Survive Ebola; Finding Points Way to New Approaches to Treatment

CDC LogoWashington, DC, July 1, 2016 ― A first-of-its-kind Ebola study yields clues to how some people are able to survive the deadly virus and suggests possible avenues for treatments that could save more lives.

Researchers at Centers for Disease Control and Prevention, Emory University School of Medicine, and University of Nebraska Medical Center analyzed the immune responses of Ebola patients treated in the United States.

Their study was recently published online in the Clinical Infectious Disease Journal in the article entitled, “Kinetic Analysis of Biomarkers in a Cohort of U.S. Patients with Ebola Virus Disease.” Continue reading

Vice President Biden Speaks on Cancer and Faith at the Vatican

Vice President Joe Biden

Vice President Joe Biden

Vatican City, May 2, 2016 ― Vice President Joseph R. Biden Jr. came to Vatican City to talk about two of his deepest passions: his Roman Catholic faith and curing cancer, Gardiner Harris reports in The New York Times.

At the Third International Regenerative Medicine Conference at the Vatican, Vice President Biden spoke about the urgent need to come up with new cures for cancer, a subject that has come to define his final year in office.

The conference is intended to highlight the extraordinary research advances being made with adult stem cells while largely sidestepping the issue of research using fetal tissue or embryonic stem cells.

“Most importantly, we want everyone to understand that no one has to choose between science and faith,” Dr. Robin Smith, president of the Stem for Life Foundation and one of the organizers of the three-day conference, said in a welcoming speech Tuesday. Continue reading

President Wants $1.9B to Fight Zika; Some House Republicans Are Unconvinced

Zika mosquitoWashington, DC, April 28, 2016 ― The Associated Press today reports that President Barack Obama’s $1.9 billion request for emergency money to combat the Zika virus has been sitting before Congress for more than two months—and there’s no obvious path forward despite a growing threat in the hot summer months and increasing public anxiety.

The administration has already transferred almost $600 million of unused Ebola funds and other money to fight Zika in the near term.  However, it says more is urgently needed to control the mosquitoes that spread the virus, manufacture vaccines once they are developed, and produce more accurate testing for the virus.

The Centers for Disease Control and Prevention said recently that no local mosquito-borne Zika virus disease cases have been reported in the U.S., but there have been 388 travel-associated cases. Continue reading

Christie Administration Recognizes Medical Laboratory Week

Cancer Research blueTrenton, NJ, April 26, 2016 ― New Jersey Acting Health Commissioner Cathleen Bennett recognizes National Medical Laboratory Professionals Week, April 24-30, by commending New Jersey’s laboratory professionals who play a vital part in every aspect of healthcare, including medical diagnosis and public health prevention.

“Every day, New Jersey’s laboratory professionals play a vital role in health care and especially in protecting the public’s health,” Acting Commissioner Bennett said.

“Laboratory professionals,” Bennett added, “work at commercial and hospital laboratories as well as the Department’s Public Health and Environmental Laboratory (PHEL) and conduct tests daily that help residents manage chronic disease, ensure drinking and recreational water is safe, detect and report disease outbreaks, and work closely with local, state and federal agencies in maintaining vigilance against bioterrorism.” Continue reading

Rutgers Scientists Identify Biological Pathway that Could Explain Why Asthma Therapies Are Ineffective

Asthma 1New Brunswick, NJ, April 20, 2016 ― Scientists from Rutgers University and the University of Pennsylvania have identified a biological pathway that could explain why current asthma therapies often prove ineffective.

The discovery has the potential to lead to new treatments for many of the 25 million people in the U.S., including seven million children, who suffer from the chronic condition.

Researchers Reynold A. Panettieri, inaugural director of the clinical and translational science institute at Rutgers, and Edward E. Morrissey, director of the Penn Center for Pulmonary Biology, determined that when certain genes in mice were inactivated, the mice developed an asthma-like condition, exhibiting airway hyper-responsiveness, or AHR, a classic sign of asthma. Continue reading

Rutgers Cancer Institute: Poor Responding Gynecologic Cancers Get Boost from Genomic Profiling

Rutgers CINJ LogoNew Brunswick, April 19, 2016 ― Research from Rutgers Cancer Institute of New Jersey examining gynecologic cancers that poorly respond to therapy shows genomic profiling can help identify alternate and targeted treatments.

The findings are being presented as part of a poster presentation by members of the Rutgers Cancer Institute precision medicine team at the Annual Meeting of the American Association for Cancer Research (AACR) which begins this weekend in New Orleans.

According to the Centers for Disease Control and Prevention, 71,500 women are diagnosed with a gynecologic cancer each year in the United States, with 26,500 deaths from one of these diseases.  Continue reading

U.S. Officials Report: The More We Know About Zika, The Scarier It Is

Zika VirusWashington, DC, April 12, 2016 ― The more researchers learn about the Zika virus, the scarier it appears, federal health officials say, as they urge more money for mosquito control and development of vaccines and treatments.

The Associated Press reports that scientists increasingly believe the Zika virus sweeping through Latin America and the Caribbean causes devastating defects in fetal brains if women become infected during pregnancy.

“Everything we look at with this virus seems to be a bit scarier than we initially thought,” Dr. Anne Schuchat of the Centers for Disease Control and Prevention said at a White House briefing.

And while experts don’t expect widespread outbreaks in the continental U.S., “we absolutely need to be ready,” she said. Continue reading

Report: U.S. Autism Cases Appear to Have Increased in 2014

Washington, DC, February 7, 2016 ― Ariana Eunjung Cha reports in The Washington Post that the number of autism cases in the United States appeared to jump dramatically in 2014 according to new estimates released in November.

However, researchers said that changes in the format of the questionnaire likely affected the numbers.

The report from the Centers for Disease Control (CDC) and Prevention and National Center for Health Statistics (NCHS) shows that the prevalence of autism in children ages 3 to 17 went up about 80 percent from 2011-2013 to 2014. Continue reading